<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02932930</url>
  </required_header>
  <id_info>
    <org_study_id>USJ-02</org_study_id>
    <nct_id>NCT02932930</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Quadratus Lumborum Block for Postoperative Pain in Abdominoplasty</brief_title>
  <official_title>Ultrasound Guided Quadratus Lumborum Block for Postoperative Pain in Abdominoplasty: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St Joseph University, Beirut, Lebanon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St Joseph University, Beirut, Lebanon</source>
  <brief_summary>
    <textblock>
      The original concept of a quadratus lumborum block (QLB) indicated for analgesia after
      abdominal surgery was first described by Blanco in 2007. Also referred to as a posterior
      transversus abdominis plane (TAP) block, the QLB consists in deposition of local anesthetic
      on either the posterior or the anterolateral border of the quadratus lumborum muscle. TAP
      blocks have already been proved effective in urologic, abdominal, and gynecologic procedures
      by blocking the sensory nerve supply to the anterior abdominal wall thus reducing the amount
      of postoperative analgesic medication. The main advantages of QLB compared to the TAP block
      is a wider sensory block area and a longer duration of analgesia. This is due to the
      extension of local anesthetic agents beyond the TAP plane to the thoracic paravertebral
      space(4).

      Previous reports have shown that QLB is effective in providing pain relief after various
      abdominal operations. However, there are no published reports on QLB for postoperative pain
      after abdominoplasty. This prospective, randomized, double-blinded, controlled study aims to
      evaluate the analgesic efficacy, opioids consumption and quality of recovery of QLB in
      patients undergoing abdominoplasty. Patients scheduled to have abdominoplasty will be
      randomized to receive bilateral QLB with either ropivacaine 0.2% or normal saline.
      Post-operative cumulative analgesic medication consumption, pain severity at rest and on
      movement, as well as quality of recovery will be evaluated and compared in both groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative morphine consumption</measure>
    <time_frame>up to 48 hour</time_frame>
    <description>Cumulative morphine consumption in mg while in the PACU and tramadol dose till 48 hour post operatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first tramadol dose</measure>
    <time_frame>up to 48 hour</time_frame>
    <description>Time to first tramadol dose: time from the discharge to the surgical ward to the first postoperative subcutaneous tramadol dose requested by the patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain severity</measure>
    <time_frame>up to 48 hour</time_frame>
    <description>Postoperative pain severity in Numerical Rating Scale at rest in the first 48 hour after surgery. Ranging from 0 for no pain to 10 for worst pain imaginable. All patients will be assessed postoperatively by a blinded investigator: at 2, 4, 6, 12, 24, 36, and 48 hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative dynamic pain severity</measure>
    <time_frame>up to 48 hour</time_frame>
    <description>Postoperative dynamic pain severity (walking, coughing, deep breathing) in Numerical Rating Scale in the first 48 hour after surgery. Ranging from 0 for no pain to 10 for worst pain imaginable. All patients will be assessed postoperatively by a blinded investigator: at 2, 4, 6, 12, 24, 36, and 48 hour postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea or vomiting</measure>
    <time_frame>up to 48 hour</time_frame>
    <description>Nausea or vomiting up to 48h post operatively (2, 4, 6, 12, 24, 36, and 48 hour postoperatively) using the following four grades scale:
0 = No nausea; 1 = Mild nausea; 2 = Moderate nausea; 3 = Severe nausea or vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>up to 48 hour</time_frame>
    <description>Sedation level up to 48 hour post operatively using the following Ramsay score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery</measure>
    <time_frame>up to 48 hour</time_frame>
    <description>Quality of recovery using the self-assessment quality of recovery (QoR) scale to assess the patient's recovery quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first walk</measure>
    <time_frame>up to 48 hour</time_frame>
    <description>Time to first walk</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>QLB group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive at the beginning of the surgery 0.2 ml/kg of 0.2% ropivacaine bilaterally.
Procedure: Quadratus Lumborum Block type II, local anesthetic injection on the posterior border of the quadratus lumborum muscle Drug: Ropivacaine, 0.2 ml/kg of 0.2% ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive at the beginning of the surgery 0.2 ml/kg of 0.9% normal saline bilaterally.
Procedure: Quadratus Lumborum Block type II, local anesthetic injection on the posterior border of the quadratus lumborum muscle Drug: Normal saline, 0.2 ml/kg of 0.9 % normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>QLB bloc</intervention_name>
    <arm_group_label>QLB group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.2% Ropivacaine</intervention_name>
    <description>0,2ml/kg of 0,2% ropivacaine</description>
    <arm_group_label>QLB group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% normal saline</intervention_name>
    <description>0,2ml/kg of 0.9% normal saline</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Standard abdominoplasty procedure

          2. Written informed consent

          3. Age â‰¥ 18 years

          4. Female

        Exclusion Criteria:

          1. Patient's refusal

          2. Allergies to any study medication

          3. Inability to comprehend or participate in scoring scales

          4. Deformations that could possibly affect the spread of the local anesthetic in the
             quadratus lumborum muscle plane

          5. Quadratus lumborum muscle plane not seen in ultrasound examination

          6. Coagulopathy or on anticoagulants
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cyril Awaida, MD</last_name>
    <phone>009613622436</phone>
    <email>cyrilawaida@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hotel Dieu De France</name>
      <address>
        <city>Beirut</city>
        <state>Aschrafieh</state>
        <zip>00961</zip>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>samer jabbour, M.D.</last_name>
      <phone>009613416234</phone>
      <email>samermed@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <reference>
    <citation>El-Boghdadly K, Elsharkawy H, Short A, Chin KJ. Quadratus Lumborum Block Nomenclature and Anatomical Considerations. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):548-9. doi: 10.1097/AAP.0000000000000411.</citation>
    <PMID>27315184</PMID>
  </reference>
  <reference>
    <citation>Hockett MM, Hembrador S, Lee A. Continuous Quadratus Lumborum Block for Postoperative Pain in Total Hip Arthroplasty: A Case Report. A A Case Rep. 2016 Sep 15;7(6):129-31. doi: 10.1213/XAA.0000000000000363.</citation>
    <PMID>27513972</PMID>
  </reference>
  <reference>
    <citation>Sforza M, Andjelkov K, Zaccheddu R, Nagi H, Colic M. Transversus abdominis plane block anesthesia in abdominoplasties. Plast Reconstr Surg. 2011 Aug;128(2):529-35. doi: 10.1097/PRS.0b013e31821e6f51.</citation>
    <PMID>21788846</PMID>
  </reference>
  <reference>
    <citation>Murouchi T, Iwasaki S, Yamakage M. Quadratus Lumborum Block: Analgesic Effects and Chronological Ropivacaine Concentrations After Laparoscopic Surgery. Reg Anesth Pain Med. 2016 Mar-Apr;41(2):146-50. doi: 10.1097/AAP.0000000000000349.</citation>
    <PMID>26735154</PMID>
  </reference>
  <reference>
    <citation>Baidya DK, Maitra S, Arora MK, Agarwal A. Quadratus lumborum block: an effective method of perioperative analgesia in children undergoing pyeloplasty. J Clin Anesth. 2015 Dec;27(8):694-6. doi: 10.1016/j.jclinane.2015.05.006. Epub 2015 Jul 11.</citation>
    <PMID>26174113</PMID>
  </reference>
  <reference>
    <citation>Blanco R, Ansari T, Girgis E. Quadratus lumborum block for postoperative pain after caesarean section: A randomised controlled trial. Eur J Anaesthesiol. 2015 Nov;32(11):812-8. doi: 10.1097/EJA.0000000000000299.</citation>
    <PMID>26225500</PMID>
  </reference>
  <reference>
    <citation>Chakraborty A, Goswami J, Patro V. Ultrasound-guided continuous quadratus lumborum block for postoperative analgesia in a pediatric patient. A A Case Rep. 2015 Feb 1;4(3):34-6. doi: 10.1213/XAA.0000000000000090.</citation>
    <PMID>25642956</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2016</study_first_submitted>
  <study_first_submitted_qc>October 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2016</study_first_posted>
  <last_update_submitted>October 13, 2016</last_update_submitted>
  <last_update_submitted_qc>October 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St Joseph University, Beirut, Lebanon</investigator_affiliation>
    <investigator_full_name>samer jabbour</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>QLB</keyword>
  <keyword>Abdominoplasty</keyword>
  <keyword>Quadratus lumborum block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

